Barrow, Hanley, Mewhinney & Strauss’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.79K Buy
+218
New +$3.92K ﹤0.01% 289
2021
Q4
Sell
-2,302
Closed -$113K 354
2021
Q3
$113K Sell
2,302
-788
-26% -$38.1K ﹤0.01% 204
2021
Q2
$131K Buy
+3,090
New +$115K ﹤0.01% 176

Other funds holding MXL

Barrow, Hanley, Mewhinney & Strauss's MXL Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss opened a new position in MaxLinear (MXL) in Q1 2026: 218 shares worth $3.79K. The stake represents ﹤0.01% of the portfolio and ranks #289 among its holdings. This is a return to the name: Barrow, Hanley, Mewhinney & Strauss previously reported a position in MXL as recently as Q3 2021.

Barrow, Hanley, Mewhinney & Strauss first reported a position in MXL in Q2 2021 and has held it in 3 quarters since. The position peaked at $131K in Q2 2021. 238 funds tracked by Wall St. Rank hold MXL as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 218 shares of MaxLinear worth $3.79K as of Q1 2026.
  • MaxLinear was a new Barrow, Hanley, Mewhinney & Strauss position in Q1 2026.
  • MaxLinear made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #289 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in MaxLinear in Q2 2021 and has held it in 3 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's MaxLinear position peaked at $131K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held MaxLinear as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.